Sensyne Health Share Discussion Threads

[rambutan2] 07/5/2021 20:11

Acacia slowing selling down and now (actually 27/04) at 8.7%:

[billy3] 07/5/2021 16:12

The Liberium figures of 100 mill tests would pay £4 mill income works out at 25p per test.

So Excalibur must be paying 50p per test.
Not bad as original guess was around 10p.

Is my maths correct ?

[zulu_principle] 07/5/2021 13:58

From Proactive Investor - includes some revenue numbers to mull over!

"Sensyne Health PLC’s (LON:SENS) announcement that its MagnifEye app to improve the accuracy of instant Covid-19 tests has received UK regulatory approval is ‘unequivocally positive’, according to broker Liberum.

"The MHRA has granted authorisation of special use alongside the Innova lateral flow test. Innova was the brand originally used to test the MagnifEye technology as part of an NHS Digital pilot study, notes Liberum. “We believe that all current NHS provided lateral flow tests are the Innova brand,” added the broker. “We estimate that there will be as many as 100mln per week of these distributed in the UK if the government hits its desired aim of every adult testing themselves twice weekly.”

"The broker added there remain many unknowns, such as how or even if MagnifEye will be integrated with these tests, but it opens a route to significant revenues for Sensyne if it can find a way to use today’s approval to strike a commercial agreement with the NHS. “In terms of the theoretical financial opportunity, even at half the royalty it gets from its current testing partner, Excalibur, the maximum revenue potential would be £4mln per week. “For context, we forecast total revenues for Sensyne of £27mln for fiscal 2022.” Shares rose by 2.5% to 167.5p."

[miti 1000] 07/5/2021 13:28

hxxps://www.voxmarkets.co.uk/articles/sensyne-health-gains-mhra-approval-for-magnifeye-ai-software-8668d45/

[billy3] 07/5/2021 10:17

How many test have they sold so far ? !!!!!



The Most Used Antigen Tests in The World. Fast, Accurate and Equitable.
Innova Medical Group is the world’s largest manufacturer of COVID tests. We’ve delivered over 500 million Innova SARS-CoV-2 rapid antigen test kits to over 20 countries.

[billy3] 07/5/2021 09:56

Great news and exactly what I’ve been talking about waiting for.

The bit I’m not so sure in that Magnifeye is licensed and exclusive to Excalibur.
So to get around that I am assuming that Excalibur will get a bit of a cut for each use ?

I’m surprised this news hasn’t pushed the price up further yet ?
I am confident that LFTs will be a big part of the next round of travel announcements by the government will make and so Sens will feature in those tests.

Innova is used widely and was used for Liverpool Mass testing.
The DHSC paid Sens for the latest pilot study and so will now expect magnifeye to be used.

Hopefully some good press coverage over the weekend in the financials.

[zulu_principle] 07/5/2021 09:45

Reported buys v sells rather misleading as of 09:35.

Halifax are quoting me 165p for a "sell" and 165.9p for a "buy". On that basis most of today's transactions are buys. Unfortunately indicates some MMs are keen to get rid of stock (not exactly a vote of confidence).

On balance I'm happy to hold and continue accumulating - quite a few positive straws in the wind over the last few weeks but the lack of reported / forecast revenues means I'll be keeping a very close watch.

[edwardt] 07/5/2021 09:28

not sure consensus is expecting too much this year. but i would hope that magnifeye could cover it alone...

[zulu_principle] 07/5/2021 08:12

What we need now is a trading update with revenue / profit projections. Managed to add another 3k at the same price as my previous 2k purchase - just in time!

[miti 1000] 07/5/2021 07:43

Yep, that is excellent news . Innova tests are widely used so this should fit in very well with upcoming govt guidance on the use of free lateral flow tests that will be used in the months to come .Sensyne should be a big beneficiary.

[davemac3] 07/5/2021 07:13

Zipperdy doo dah

[zulu_principle] 05/5/2021 12:37

billy3 - many thanks, great link. Still very high risk but worth another couple thousand.

[rambutan2] 05/5/2021 03:42

Thanks billy. Has the potential to be a real headline grabber if all goes well.

[billy3] 04/5/2021 16:08

Its in part iv

[rambutan2] 04/5/2021 15:29

billy3, can you provide a link to the info you are providing. Thanks.

[billy3] 04/5/2021 13:45

Reading the award contract by the government to Sensyne to test Magnifye in the next stage,its interesting to see that they have avoided a full tender by confiriming that SENS are the only company that have this software/method of reading test results.

Reads as follows....................




3. DHSC is satisfied that the tests permitting use of the Negotiated procedure without prior publication (Regulation 32(2)(b)(ii)) are met because:A.

The works, supplies or services can be supplied only by a particular economic operator as competition is absent for technical reasons:

The proof of concept work being carried out by the supplier is to demonstrate, refine and retrain specialist software and algorithms which are protected by IPRs held solely by the supplier.

No other supplier is capable of providing the same software, technology and algorithm in the short time frames required for the pilot phase of the proof of concept which is a pre-condition to the roll out of the technology to NHS professionals and in time the general public.

B. No reasonable alternative or substitute exists:

There is no reasonable alternative operator who can provide the technology, software and algorithms to run the proof of concept and pilot the expanded testing capabilities without interruption at this stage.

The imperative of innovation and the need to rapidly expand the scope and capacity of testing services is critical to England’s response to the COVID-19 outbreak and the significant benefits of successful containment of the spread of the virus is self-evident.

If DHSC is unable to continue with its investigations into innovative solutions that could rapidly increase testing capacity and speeds, this may have a catastrophic impact on its strategy and could result in further spreading of the virus due to difficulties in testing and isolating those who have tested positive.

C. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement:

This procurement is part of a procurement strategy by the UK government to increase testing capacity exponentially to meet demand due to the Covid-19 pandemic.
Other Information

[billy3] 02/5/2021 07:17

So the news this morning is that a governmemt have said that pilot study has concluded that people could be able to take Lateral flow tests daily for a week as an alternative to isolation after being open to COVID after activities such as travel. This is now going to be a trial starting in a weeks time.

Putting 2 and 2 together, this has to be the pilot that the government paid Sensyne nearly half a million for the second stage pilot back in March. The numbers eventually needing the tests could be up to 40k. What leads me to think it will involve sensyne is that it is the best test around using Excalibur but with the best way of reading using magnify. Better than the Human eye and an end to end process for reading and recording.

Fingers crossed this gets approved and Sensynes name is all over the announcement. So far, they’ve not be specifically named.

[rambutan2] 30/4/2021 22:11

30 April 2021

Sensyne Health and Royal Devon and Exeter NHS Foundation Trust sign Strategic Research Agreement

New agreement combined with NHS England approval of SRAs with George Eliot Hospital NHS Trust and Wye Valley NHS Trust brings combined total of anonymised data available to Sensyne to 8.5 million patients

[edwardt] 27/4/2021 10:41

what abont the govt contract? seems to me that could expand...

[davemac3] 27/4/2021 10:14

it's exclusive to Excalibur

[edwardt] 27/4/2021 08:04

my kids are at school and they manually have to put their results of lateral flow tests on nhs website twice a week. . what if the app for magnifeye can circumvent that process? surely that will a) improve results a lot b) improve processing errors and reduce time and cost of doing the test. am i missing something but apply this software to european and us markets and we are onto something enormous...

[wanttowin] 15/4/2021 11:32

I'm still holding billy, but not much to comment on at the moment.
I had expected a flurry of posts re the excellent news announced recently.
Getting a march on now !